HEALTH● ELEVATEDSep 14 · Sep 14, 2026, 5:03 AM
US push to cut drug prices could mean longer waits for European patients
EuroNews [en] · global
Europe’s patients could face longer waits for some new medicines as US efforts to drive down drug prices risk encouraging pharmaceutical companies to delay launches in lower-price markets, according to a new modelling study.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h ago161 confirmed measles cases, one death reported in KozhikodeThe HinduHEALTH3h agoLongevity-first healthcare takes spotlight at Abu Dhabi Future Health SummitSouth China Morning PostHEALTH3h agoKenya’s Ebola cases test preparedness beyond NairobiAl Jazeera [en]HEALTH5h agoEven after explosive diarrhea outbreak Trump’s FDA looks to ease food requirementsThe Independent World